Sophia Genetics Financials - Benzinga

Sophia Genetics SA

SOPHNASDAQ

Trade with Public

Trade with Public

$8.26

0.182.23%

近くで: Sep 23, 5:00 PM EST

$8.26

0.182.23%

プレマーケット: 4:00 AM EST

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Sophia Genetics Financials

Sophia Genetics (SOPH) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Sophia Genetics Raises FY2026 Sales Guidance from $92.000M-$94.000M to $94.000M-$96.000M vs $93.403M Est

Sophia Genetics (NASDAQ:SOPH) raises FY2026 sales outlook from $92.000 million-$94.000 million to $94.000 million-$96.000 million vs $93.403 million estimate.

Benzinga Newsdesk

PRO
Sophia Genetics Q2 EPS $(0.30) Misses $(0.20) Estimate, Sales $23.310M Beat $21.729M Estimate

Sophia Genetics (NASDAQ:SOPH) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.20) by 50 percent. This is a 9.09 percent increase over losses of $(0.33) per share from

Benzinga Newsdesk

Stock Market Today: Dow Futures Tumble, S&P 500, Nasdaq Gains As Investors Await FOMC Decision— Amkor, La-Z-Boy In Focus (UPDATED)

(Editor’s note: The future prices of benchmark tracking ETFs and the headline were updated in the story.) U.S. stock futures were mixed on Wednesday, as the Dow Jones fell, while the Nasdaq 100 and S&P 500 advanced, following Tuesday’s mixed close.

Rishabh Mishra

CarMax, Jabil And 3 Stocks To Watch Heading Into Wednesday

U.S. stock futures trading higher. CarMax, Sophia Genetics, Jabil, La-Z-Boy, and Safe Bulkers in focus. La-Z-Boy shares jump 17.7% after earnings.

Avi Kapoor

Earnings Scheduled For May 5, 2026

Benzinga Insights

PRO
Sophia Genetics Affirms FY2026 Sales Guidance of $92.000M-$94.000M vs $93.250M Est

Sophia Genetics (NASDAQ:SOPH) affirms FY2026 sales outlook from $92.000 million-$94.000 million to $92.000 million-$94.000 million vs $93.250 million estimate.

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved